Search results
Results from the WOW.Com Content Network
Polyestradiol phosphate (PEP), sold under the brand name Estradurin, is an estrogen medication which is used primarily in the treatment of prostate cancer in men. [1] [9] [2] [10] It is also used in women to treat breast cancer, as a component of hormone therapy to treat low estrogen levels and menopausal symptoms, and as a component of feminizing hormone therapy for transgender women.
Now, new research finds that women who use hormone therapy after age 65 are usually fine to do just that — but the dose and timing of the treatment matter. The study, which was published in ...
Hydroxyprogesterone caproate has been used as a component of menopausal hormone therapy in women. [43] [44] Hydroxyprogesterone caproate has been used to treat benign prostatic hyperplasia in men, although evidence of effectiveness is marginal and uncertain. [45] It has also been used to treat prostate cancer, at a dosage of 1,500 mg twice per ...
Doctors urge most men to get screened for prostate cancer starting at age 50, he says. But if you’re in a high-risk group, including Black men or anyone with a family history of the disease, get ...
In men with metastatic, hormone-sensitive prostate cancer, doctors may recommend adding taxane-based chemotherapy to hormone therapy. [45] This combination likely improves overall and cancer-specific survival by slowing the spread of the cancer. However, taxane-based chemotherapy may cause an increase in side effects. [45]
[4] [206] Hence, area-under-curve levels of the medication were 1.6 to 1.8 times higher in those who were 65 years of age or older relative to those who were 60 years of age or younger. [ 9 ] [ 206 ] As such, levels of MPA have been found to vary with age, and MPA may have an increased risk of side effects in elderly postmenopausal women.
Orchiectomy, LHRH analogs and LHRH antagonists can all cause similar side effects, due to changes in the levels of sex hormones (testosterone). [17] A program has been developed for patients and their partners to recognize and manage the more burdensome side effects of androgen deprivation therapy.
After undergoing surgery for prostate cancer in October, the travel writer, 69, says the side effects have helped him better understand women's bathroom needs